We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Get the latest from JAMA Psychiatry
Please Wait... Processing your request... Please Wait.

Not a subscriber yet?

Subscribe to JAMA Psychiatry for 12 months of high-impact, peer-reviewed original articles and unique features. Subscribe/Learn More

JAMA Psychiatry Tweets

Follow us on Twitter

Connect with us on Google+

Current Highlights

Follow Us

Original Investigation | July 1, 2015 FREE ONLINE FIRST

Treatment of Young People With Antipsychotic Medications

This pharmacoepidemiology study reports increased use of antipsychotic medication from 2006 to 2010 in adolescents and young adults.

Original Investigation | June 24, 2015 FREE ONLINE FIRST

Long-Acting Injectable Risperidone After First Episode of Schizophrenia

This randomized clinical trial shows that long-acting injectable risperidone resulted in better clinical outcomes than oral risperidone.

Original Investigation | June 17, 2015 ONLINE FIRST

Serotonin Synthesis and Reuptake in Social Anxiety Disorder

This cross-sectional positron emission tomography study describes an overactive presynaptic serotonin system, with increased serotonin synthesis and transporter availability, in patients with social anxiety disorder.

Original Investigation | June 10, 2015 ONLINE FIRST

ASD Subcortical and Cortical Resting State Networks

This resting-state functional magnetic resonance imaging study compares the intrinsic functional connectivity between brain networks in a large sample of individuals with autism spectrum disorder and typically developing control subjects.

Original Investigation | June 3, 2015 FREE ONLINE FIRST

Epidemiology of DSM-5 Alcohol Use Disorder

This national epidemiologic survey finds that alcohol use disorder is highly prevalent, highly comorbid, and disabling, with an urgent need for education of the public and policy makers, destigmatization of the disorder, and encouragement of those with the disorder to seek treatment.

Explore more articles:  Current Issue | Online First

Multimedia >

Author Interview

Author photo

Interview with Marleen H. M. de Moor, PhD, author of Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder

audio player


Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder

All Author Interviews >

Article Video

Video thumbnail

The Tradition and Future of JAMA Psychiatry (02:22)

Stephan Heckers, MD, Editor, provides an overview of JAMA Psychiatry.

All Article Videos >


Interactive preview

All Interactive >

Author Readings
Author photo

audio player


Reader Comments

Introducing Reader Comments, a new way for readers to discuss JAMA Psychiatry articles. Select the Comments tab on article pages to read any comments and submit your own. Letters submitted to JAMA Psychiatry for consideration for print and online (archival) publication but not accepted may be accepted as Comments.

Firearm Violence

Articles from the JAMA Network

Image of JAMA forum logo

Physician Jobs